Concepedia

Brenda O’Connell

BO

Statistics

Publications

17

Citations

2K

H-Index

16

Active since

2000

Affiliations

Infinity Pharmaceuticals (United States)(Current)

Massachusetts General Hospital

University of California, Los Angeles

Brown University

Memorial Sloan Kettering Cancer Center

Brenda O’Connell is an author at Infinity Pharmaceuticals (United States) specializing in molecular biology, life sciences, and medicine.

ORCID

Publications per year

2000–2024

17

Publications

17

Identification of <i>CDK4</i> as a target of c-MYC

Heiko Hermeking, Carlo Rago, Marino Schuhmacher et al. · Proceedings of the National Academy of Sciences · 2000 · 480 citations · Full text

, , +17

Mammalian BTBD12/SLX4 Assembles A Holliday Junction Resolvase and Is Required for DNA Repair

Jennifer M. Svendsen, Agata Smogorzewska, Mathew E. Sowa et al. · Cell · 2009 · 451 citations · Full text

, , +10

A Large Scale Genetic Analysis of c-Myc-regulated Gene Expression Patterns

Brenda O’Connell, Ann Cheung, Carl P. Simkevich et al. · Journal of Biological Chemistry · 2003 · 227 citations · Full text

, , +17

A Functional Screen for Myc-Responsive Genes Reveals Serine Hydroxymethyltransferase, a Major Source of the One-Carbon Unit for Cell Metabolism

Mikhail A. Nikiforov, Sanjay Chandriani, Brenda O’Connell et al. · Molecular and Cellular Biology · 2002 · 201 citations · Full text

, , +17

A Genome-wide Camptothecin Sensitivity Screen Identifies a Mammalian MMS22L-NFKBIL2 Complex Required for Genomic Stability

Brenda O’Connell, Britt Adamson, John R. Lydeard et al. · Molecular Cell · 2010 · 124 citations · Full text

, , +11

1–5 of 17